Aster DM Healthcare Limited, along with its material subsidiary Malabar Institute of Medical Sciences (MIMS), has successfully completed the 26% equity stake acquisition in Oyster Green Hybrid Two Private Limited. The transaction, involving a total investment of INR 5.80 Crores, supports the company’s objective to integrate renewable energy into its operations. The acquisition, finalized on April 22, 2026, follows a downward revision from the initially planned investment amount.
Deal Rationale and Strategic Goals
Aster DM Healthcare and its subsidiary, MIMS, have finalized the acquisition of a 26% stake in Oyster Green Hybrid Two Private Limited. The move is a strategic step toward self-sufficiency in energy management. The company intends to meet a significant portion of its total electricity requirements through renewable sources by partnering with a specialized power producer.
Oyster Green Hybrid Two is tasked with the development, installation, and maintenance of an 18 MWp captive solar power plant situated in Kerala. As part of this arrangement, the Group will purchase 100% of the net electricity output generated by the facility. This partnership aligns with statutory requirements under the Electricity Act, which mandate that captive users hold at least 26% ownership in such power projects.
Investment Details and Project Timeline
The total consideration for the acquisition has been settled at INR 5,80,00,000, revised downward from the original estimate of INR 7,00,00,000 due to a reduction in overall project costs.
The investment was executed in two distinct tranches:
- Tranche 1: INR 3,54,00,000 invested on October 02, 2025.
- Tranche 2: INR 2,26,00,000 invested on April 22, 2026.
With the completion of the share allotment for the second tranche, the Group has officially finalized its 26% equity interest in the solar energy entity, marking a key milestone in the company’s sustainability roadmap.
Source: BSE
